BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29042418)

  • 21. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma.
    Yokomakura N; Natsugoe S; Okumura H; Ikeda R; Uchikado Y; Mataki Y; Takatori H; Matsumoto M; Owaki T; Ishigami S; Aikou T
    Oncol Rep; 2007 Sep; 18(3):561-7. PubMed ID: 17671702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas.
    Qian D; Zhang B; He LR; Cai MY; Mai SJ; Liao YJ; Liu YH; Lin MC; Bian XW; Zeng YX; Huang JJ; Kung HF; Xie D
    J Pathol; 2013 Apr; 229(5):765-74. PubMed ID: 23341363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diisopropylamine dichloroacetate enhances radiosensitization in esophageal squamous cell carcinoma by increasing mitochondria-derived reactive oxygen species levels.
    Dong G; Chen Q; Jiang F; Yu D; Mao Q; Xia W; Shi R; Wang J; Xu L
    Oncotarget; 2016 Oct; 7(42):68170-68178. PubMed ID: 27626688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-associated Fibroblast-promoted LncRNA
    Zhang H; Hua Y; Jiang Z; Yue J; Shi M; Zhen X; Zhang X; Yang L; Zhou R; Wu S
    Clin Cancer Res; 2019 Mar; 25(6):1989-2000. PubMed ID: 30463848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The AEG-1-USP10-PARP1 axis confers radioresistance in esophageal squamous cell carcinoma via facilitating homologous recombination-dependent DNA damage repair.
    Zhao X; Ma Y; Li J; Sun X; Sun Y; Qu F; Shi X; Xie Y; Liu S; Ma Y; Ji C; Hu W; Che S; Zhang X
    Cancer Lett; 2023 Nov; 577():216440. PubMed ID: 37838281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma.
    Park M; Yoon HJ; Kang MC; Kwon J; Lee HW
    Tumour Biol; 2016 Oct; 37(10):14217-14224. PubMed ID: 27557627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population and single‑cell transcriptome analyses reveal diverse transcriptional changes associated with radioresistance in esophageal squamous cell carcinoma.
    Wu H; Yu J; Kong D; Xu Y; Zhang Z; Shui J; Li Z; Luo H; Wang K
    Int J Oncol; 2019 Dec; 55(6):1237-1248. PubMed ID: 31638164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human positive cofactor 4 radiosensitizes human esophageal squmaous cell carcinoma cells by suppressing XLF-mediated nonhomologous end joining.
    Qian D; Zhang B; Zeng XL; Le Blanc JM; Guo YH; Xue C; Jiang C; Wang HH; Zhao TS; Meng MB; Zhao LJ; Hao JH; Wang P; Xie D; Lu B; Yuan ZY
    Cell Death Dis; 2014 Oct; 5(10):e1461. PubMed ID: 25321468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of microRNA-98 increases radiosensitivity in esophageal squamous cell carcinoma.
    Jin YY; Chen QJ; Wei Y; Wang YL; Wang ZW; Xu K; He Y; Ma HB
    J Radiat Res; 2016 Sep; 57(5):468-476. PubMed ID: 27422937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA MALAT1 affects the efficacy of radiotherapy for esophageal squamous cell carcinoma by regulating Cks1 expression.
    Li Z; Zhou Y; Tu B; Bu Y; Liu A; Kong J
    J Oral Pathol Med; 2017 Sep; 46(8):583-590. PubMed ID: 27935117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcription factor NFE2L3 promotes the proliferation of esophageal squamous cell carcinoma cells and causes radiotherapy resistance by regulating IL-6.
    Chen T; Xu B; Chen H; Sun Y; Song J; Sun X; Zhang X; Hua W
    Comput Methods Programs Biomed; 2022 Nov; 226():107102. PubMed ID: 36108571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma.
    Yang C; Wang Y; Zhang F; Sun G; Li C; Jing S; Liu Q; Cheng Y
    Mol Biol Rep; 2013 Sep; 40(9):5225-35. PubMed ID: 23943380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
    Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
    Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lobaplatin promotes radiosensitivity, induces apoptosis, attenuates cancer stemness and inhibits proliferation through PI3K/AKT pathway in esophageal squamous cell carcinoma.
    Pan S; Sun Y; Sui D; Yang T; Fu S; Wang J; Hui B; Xi R; He C; Zhang X
    Biomed Pharmacother; 2018 Jun; 102():567-574. PubMed ID: 29597090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma.
    Zang C; Liu X; Li B; He Y; Jing S; He Y; Wu W; Zhang B; Ma S; Dai W; Li S; Peng Z
    Oncotarget; 2017 Feb; 8(7):11228-11238. PubMed ID: 28061440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma.
    Luo LL; Zhao L; Wang YX; Tian XP; Xi M; Shen JX; He LR; Li QQ; Liu SL; Zhang P; Xie D; Liu MZ
    Sci Rep; 2015 Dec; 5():17336. PubMed ID: 26670461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sp1-mediated transcriptional activation of miR-205 promotes radioresistance in esophageal squamous cell carcinoma.
    Pan F; Mao H; Bu F; Tong X; Li J; Zhang S; Liu X; Wang L; Wu L; Chen R; Wei H; Li B; Li C; Yang Y; Steer CJ; Zhao J; Guo Y
    Oncotarget; 2017 Jan; 8(4):5735-5752. PubMed ID: 27974696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PBX1 Increases the Radiosensitivity of Oesophageal Squamous Cancer by Targeting of STAT3.
    Yu D; Ma Y; Feng C; Ma Z; Guo J; Chen H; He T; Guo J; Sun X; Qin Q; Sun X; Ma J
    Pathol Oncol Res; 2020 Oct; 26(4):2161-2168. PubMed ID: 32170580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of SOCS6 confers radioresistance in esophageal squamous cell carcinoma.
    Ma R; Shi M; Hu J; Zhao LN
    Biochem Biophys Res Commun; 2021 Apr; 550():92-98. PubMed ID: 33689885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
    Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.